Position in AURA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$89,646
+$16,616 QoQ
Shares Held
13,400
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BROWN ADVISORY INC holds $209,016,512 across 24 Biotechnology names. AURA ranks #21 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,451,048 | $75,831,766 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
133,953 | $44,321,027 | |
| 3 | CYTK |
Cytokinetics Inc
|
614,655 | $40,511,910 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
511,701 | $29,734,945 | |
| 5 | INSM |
INSMED Inc
|
22,949 | $3,752,620 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,653 | $3,417,370 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,264 | $2,521,896 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
36,225 | $2,341,221 |
All Filings in AURA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $89,646 | 13,400 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $73,030 | 13,400 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||